Makale Adı Makale Tarihi
Androgen-deprivation therapies for prostate cancerrisk of infecti... 22.03.2021
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarci... 08.03.2021
Cemiplimab monotherapy for first-line treatment of advanced non-s... 01.03.2021
Cemiplimab monotherapy for first-line treatment of advanced non-s... 01.03.2021
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Trea... 22.02.2021
Cytoreductive surgery plus hyperthermic intraperitoneal chemother... 15.02.2021
Neurologic Complications of Lung Cancer 08.02.2021
Osimertinib in Resected EGFR Mutated Non Small Cell Lung Cancer 01.02.2021
Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced... 25.01.2021
Cancer Statistics, 2021 18.01.2021
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients ... 09.11.2020
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients ... 09.11.2020
Survival with Olaparib in Metastatic Castration-Resistant Prostat... 13.10.2020
Atezolizumab withwithout chemotherapy in metastatic urothelial ca... 02.09.2020
Ripretinib in patients with advanced gastrointestinal stromal tum... 26.07.2020
Tepotinib in Non?Small-Cell Lung Cancer with MET Exon 14 Skipping... 01.07.2020
Imbrave 150 Çalışması (Atezolizumab plus Bevacizumab in Unresecta... 03.06.2020
I?MMUNED Trial Adjuvant nivolumab plus ipilimumabnivolumab monoth... 23.05.2020
JCO Keynote 189 04.05.2020
1. Cancer patients in SARS-CoV-2 infection: a nationwide analysis... 29.03.2020
2. SARS-CoV-2 Transmission in Patients with Cancer at a Tertiary ... 29.03.2020
Long-term overall survivalprognostic score predicting survival : ... 03.02.2020
Checkmate-227 KHDAK 27.01.2020